Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts
Press release – No. 19 / 2026 Zealand Pharma announces opening of new Research Hub in Cambridge, Massachusetts Builds on the Metabolic Frontier 2030 strategy, advancing its ambition to become a leader in obesity and metabolic health…
Total number of shares and voting rights in Zealand Pharma as of September 30, 2026
Company announcement – No. 51 / 2026 Total number of shares and voting rights in Zealand Pharma as of September 30, 2026 Copenhagen, Denmark, September 30, 2026 – Zealand Pharma A/S (“Zealand Pharma” or 'the Company')…
There's one pharma-linked stock most investors have never heard of. It's on Josh Brown's list
(This is The Best Stocks in the Market, brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh — There's a good chance you've never heard of West Pharmaceutical Services (WST). There's an even better chance you've…
Amplio Pharma Reports Positive Early Clinical Results for NovoBioJect, Designed to Make the World's Most-Used Rheumatoid Arthritis Drug Work for More Patients
A single dose of NovoBioJect increased the active form of methotrexate inside patients' immune cells by 38%, a first step toward a potential next-generation first-line treatment for rheumatoid arthritis First clinical proof of principle. In an…
Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy?
Whether it's biotech stocks or regular pharmaceutical stocks, when investors buy a particular name in healthcare, they are making a wager on a single company's pipeline. However, there is one unique name within this space that enables investors to…
China eyes competition with Big Pharma over next 5 years
China is making it clear that it wants to become a powerhouse on a par with large Western pharmaceutical companies in the near future, and not just strike licensing deals for promising new drug candidates. Why it matters: Some experts warn that big…
Big pharma move to dispense GLP-1s to your door condemned by doctors
Eli Lilly's new online platform LillyDirect will dispense certain medicines, starting with Mounjaro, directly to a patient's door. Doctors and pharmacists have criticised the move, arguing it poses a risk to patient safety. Eli Lilly has defended…
Zealand Pharma announces Boehringer Ingelheim's survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes
Company announcement – No. 52 / 2026 Zealand Pharma announces Boehringer Ingelheim's survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type…
OnDosis and Adare Pharma Solutions announce strategic collaboration to advance OnDosis's lead U.S. ADHD program
OnDosis AB ('OnDosis'), a Swedish life science company developing drug device combinations for precision dosing of oral solid medicines based on the Dosage Manager device platform, and Adare Pharma Solutions ('Adare'), a technology-driven…
Arcus agrees to buy SK Pharma from Syz Capital and Saturnus Capital
A verification email is on its way to you. Please check your spam or junk folder just in case. If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email:.
Big Pharma Got Its Tariff Exemption. The Biotech ETF Barely Blinked
The second phase of the Section 232 tariff on imported patented drugs and their key ingredients began on September 29, 2026. That extended a duty that has covered a first group of named companies since July 31, 2026, to every other drugmaker. The…
Avalyn Pharma Inc. (NASDAQ:AVLN) Stock Now Rated 'Moderate Buy' by Wall Street Analysts
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) has earned a consensus recommendation of 'Moderate Buy' from the six research firms that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock…
Nxera Announces Successful Resolution of miniG Patent Infringement Action
Tokyo, Japan and Cambridge and London, UK, 30 September 2026 – Nxera Pharma Co., Ltd. (“Nxera Pharma” or “the Company”; TSE 4565) announces that its wholly owned subsidiary Nxera Pharma UK Limited…
Avalyn Pharma (NASDAQ:AVLN) Stock Jumps 6.4% - Here's What Happened
Avalyn Pharma Inc. (NASDAQ:AVLN - Get Free Report) shares were up 6.4% on Wednesday. The stock traded as high as $28.87 and last traded at $28.84. 160,187 shares changed hands during trading, a decline of 48% from the average daily volume of…
Boehringer, Zealand Obesity Drug's 13% Weight Loss Disappoints
Boehringer Ingelheim GmbH 's and Zealand Pharma A/S 's experimental obesity drug survodutide helped patients with diabetes shed as much as 13.1% of their weight, disappointing investors. Zealand shares fell as much as 13% in Copenhagen trading…
Receive a Daily briefing on Pharma Industry News
Get Started